Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Vaccine-induced responses

Immune signature atlas of vaccines: learning from the good responders

This article has been updated

Understanding immune determinants of vaccine-mediated immunogenicity could further provide rational vaccine design. Two research groups revealed pre-existing and early innate immune signatures associated with better vaccine-mediated antibody responses.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Pre-existing and early immune responses associated with vaccine-mediated antibody responsiveness.

Change history

  • 02 December 2022

    In the version of this article initially published, the mention of Steven Kleinstein was missing from the first paragraph summary now reading “In this issue of Nature Immunology, the groups of Kleinstein, Sekaly and Pulendran used systems-based approaches to address this challenge”. The change has been made to the HTML and PDF versions of the article.

References

  1. Li, S. et al. Nat. Immunol. 15, 195–204 (2013).

    Article  Google Scholar 

  2. Fourati, S. et al. Nat. Immunol. https://doi.org/10.1038/s41590-022-01329-5 (2022).

    Article  Google Scholar 

  3. Sweeney, T. E., Wong, H. R. & Khatri, P. Sci. Transl. Med. 8, 346ra91 (2016).

    Article  Google Scholar 

  4. Hagan, T. et al. Nat. Immunol. https://doi.org/10.1038/s41590-022-01328-6 (2022).

    Article  Google Scholar 

  5. Bradley, T. et al. Cell 175, 387–399.e17 (2018).

    Article  CAS  Google Scholar 

  6. Thurmond, S., Wang, B., Song, J. & Hai, R. Viruses 10, 712 (2018).

    Article  CAS  Google Scholar 

  7. Klein, S. L. & Flanagan, K. L. Nat. Rev. Immunol. 16, 626–638 (2016).

    Article  CAS  Google Scholar 

  8. Rondy, M. et al. J. Infect. 75, 381–394 (2017).

    Article  Google Scholar 

  9. Klein, S. L., Jedlicka, A. & Pekosz, A. Lancet Infect. Dis. 10, 338–349 (2010).

    Article  Google Scholar 

  10. Atyeo, C. G. et al. Nat. Commun. 13, 3571 (2022).

    Article  CAS  Google Scholar 

  11. Arunachalam, P. S. et al. Nature 596, 410–416 (2021).

    Article  CAS  Google Scholar 

  12. Wang, W. et al. J. Biol. Rhythms 37, 124–129 (2022).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

I.P.-P. and A.J.M. are funded by US National Institutes of Health/National Institute of Allergy and Infectious Diseases UM1 AI 00645 and the Duke Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andrew J. McMichael.

Ethics declarations

Competing interests

A.J.M. is a consultant to and SAB member of Osivax and of Oxford Vacmedix.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pedroza-Pacheco, I., McMichael, A.J. Immune signature atlas of vaccines: learning from the good responders. Nat Immunol 23, 1654–1656 (2022). https://doi.org/10.1038/s41590-022-01361-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41590-022-01361-5

Search

Quick links

Nature Briefing Microbiology

Sign up for the Nature Briefing: Microbiology newsletter — what matters in microbiology research, free to your inbox weekly.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing: Microbiology